Patient experience in systemic lupus erythematosus: development of novel patient-reported symptom and patient-reported impact measures

BACKGROUND: Comprehensive assessment of systemic lupus erythematosus (SLE) and its treatment requires patient-reported outcome (PRO) measures to capture impacts and fluctuating symptoms. The objective of this study was to develop PROs, in accordance with the Food and Drug Administration (FDA) PRO Gu...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathias, S. D., Berry, P., De Vries, J., Pascoe, K., Colwell, H. H., Chang, D. J., Askanase, A. D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934913/
https://www.ncbi.nlm.nih.gov/pubmed/29757295
http://dx.doi.org/10.1186/s41687-018-0028-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934913/
https://www.ncbi.nlm.nih.gov/pubmed/29757295
http://dx.doi.org/10.1186/s41687-018-0028-7

Ejemplares similares